The impact of an etoposide shortage on patients with extensive-stage small cell lung cancer (ES-SCLC): Results of a natural experiment

被引：0
|
作者：
Browne, C. [1 ]
Ayoube, T. [2 ]
Samarasinghe, N. [3 ]
Hussaini, K. [4 ]
Warner, A. [5 ]
Black, M. [6 ]
Palma, D. A. [6 ]
Raphael, J. [6 ]
Kuruvilla, M. S. [6 ]
Blanchette, P. [6 ]
机构：
[1] Univ Western Ontario, Med Oncol, London, ON, Canada
[2] Univ Western Ontario, Sci, London, ON, Canada
[3] Univ British Columbia, Surg, Fac Med, Vancouver Gen Hosp, Vancouver, BC, Canada
[4] Oakville Trafalgar Mem Hosp, Dept Oncol, London, ON, Canada
[5] London Hlth Sci Ctr, Dept Radiat Oncol, London Reg Canc Program LRCP, London, ON, Canada
[6] London Hlth Sci Ctr, Dept Med Oncol, London Reg Canc Program LRCP, London, ON, Canada
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1227
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1996P
引用
收藏
页码：S1065 / S1065
页数：1
相关论文
共 50 条
  • [1] Anlotinib Combined with Etoposide as Maintenance Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Shen, B.
    Wu, Y.
    Shi, L.
    Feng, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S509 - S510
  • [2] Paraneoplastic acquired haemophilia A in extensive-stage small cell lung cancer (ES-SCLC) in the era of immunotherapy
    Pauls, Mehrnoosh
    Rydz, Natalia
    Nixon, Nancy A.
    Ezeife, Doreen
    BMJ CASE REPORTS, 2021, 14 (01)
  • [3] Prognostic impact of Neutrophil-to-Lymphocyte Ratio (NLR) For Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Ishihara, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S684 - S685
  • [4] Patterns of Disease Progression after Carboplatin/Etoposide plus Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)
    Higgins, K. A.
    Curran, W. J., Jr.
    Liu, S. V.
    Yu, W.
    Brockman, M.
    Johnson, A.
    Bara, I.
    Bradley, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (05): : 1398 - 1398
  • [5] Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer (ES-SCLC): A tertiary cancer centre experience
    Srivastava, A.
    Shelly, K.
    Lin, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S46 - S47
  • [6] Anlotinib combined with etoposide as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): Updated results from a phase II trial.
    Shen, Bo
    Wu, Yuan
    Shi, Lin
    Pan, Banzhou
    Yang, Kaihua
    Wang, Qiong
    Zhao, Weiqing
    Han, Zhengxiang
    Wang, Lifeng
    Feng, Jifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] COST OF IMMUNOTHERAPY TO TREAT EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)
    Bilir, S. P.
    Ogale, S.
    VALUE IN HEALTH, 2020, 23 : S36 - S36
  • [8] Atezolizumab (ATZ) plus carboplatin (Cb) and etoposide (eto) in patients with untreated extensive-stage small cell lung cancer (ES-SCLC): Results from the interim analysis of MAURIS trial
    Bria, E.
    Garassino, M. C.
    Del Signore, E.
    Morgillo, F.
    Spinnato, F.
    Morabito, A.
    Iero, M.
    Ardizzoni, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1248 - S1248
  • [9] Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy
    Slotman, B. J.
    Faivre-Finn, C.
    van Tinteren, H.
    Keijser, A.
    Praag, J. O.
    Knegjens, J.
    Hatton, M.
    van Dam, I.
    van der Leest, A.
    Reymen, B.
    Stigt, J.
    Haslett, K.
    Tripathi, D.
    Smit, E.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S153 - S154
  • [10] Burden of Chemotherapy-induced Myelosuppression on Patients with Extensive-stage Small Cell Lung Cancer (ES-SCLC) from the Perspective of Patients and Caregivers
    Abraham, Ivo
    Zincavage, Rebekah
    Ito, Diane
    Padilla, Brad
    Sussman, Matthew
    Moore, Michelle
    Huang, Huan
    Crawford, Jeffrey
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E18 - E18
12345